THE SURVIVAL OF TRANSFUSED ERYTHROCYTES
ing blood count: R.B.C.11 million, W.B.C. 17,000, Hb 156%, and a haematocrit of 84; (3) a man aged 61, first seen in March, 1950, when he had a blood count of R.B.C. 8.7 million, W.B.C. 81,000, Hb 126%, haematocrit 58, and was found to have a myelosclerotic bone marrow. This latter association in certain cases of polycythaemia vera has recently been stressed by Dameshek (1950) .
The recipients were (1) a normal man, aged 28; (2) a man aged 42, suffering from carcinoma of the bronchus, whose general condition was initially satisfactory, except for a slowly resolving paraplegia due to spinal secondaries; (3) a woman aged 62, recovering from a cerebral thrombosis and with mild iron deficiency anaemia.
Unfortunately, six weeks after transfusion, the second recipient died from cerebral secondaries, which became manifest four weeks after transfusion.
Technique Approximately 1 pint of citrated blood from a polycythaemic donor was transfused ,after storing for 24 hours into the recipient. The day after transfusion and at intervals thereafter the surviving cells were estimated by differential agglutination, using the ABO system. This was carried out by Dacie's method (1950 Results The results are shown in Fig. 1 and Table 1 . The survival of cells from polycvthaemic patients was found to be normal in the experiments which were completed. The rate of destruction in the patient who died six weeks after transfusion was also found to be normal. Summary
Otur observations show that the life span of transfused red cells from cases of primary polycythaemia is normal. These results confirm the findings of Merskey (1949) , who used a similar differential agglutination technique. There is further confirmation that the red cell life in primary polycythaemia is normal. Using another technique (with isotopic nitrogen), London, Shemin, West, and Rittenberg (1949) have shown in one case that the otherwise undisturbed red cell in a polycythaemic patient has a normal life span.
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